Navigation Links
Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
Date:8/13/2009

THOUSAND OAKS, Calif., Aug. 13 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) issued the following statement on the outcome of today's meeting with the U.S. Food and Drug Administration (FDA) Advisory Committee for Reproductive Health Drugs (ACRHD) to review the potential use of Prolia(TM) (denosumab) for the prevention and treatment of postmenopausal osteoporosis and the prevention and treatment of bone loss in patients undergoing hormone ablation for either prostate cancer or breast cancer.

After reviewing safety and efficacy data from 30 clinical studies involving more than 12,000 patients, the Committee recommended approval of Prolia for the treatment of postmenopausal osteoporosis and for the treatment of bone loss in patients undergoing hormone ablation for prostate cancer. The Committee recommended against approval of Prolia to treat or prevent bone loss in women with breast cancer undergoing hormone ablation until additional data are available.

The Committee also recommended against approval of Prolia to prevent bone loss in low-risk patients in all three populations.

Finally, the panel recommended that Prolia have a Risk Evaluation and Mitigation Strategy (REMS), which could include a medication guide and a healthcare provider communications plan.

The FDA often seeks the advice of an advisory committee such as the ACRHD when evaluating a potential new treatment but is not required to follow its recommendation.

Postmenopausal osteoporosis is a major public health concern resulting in fractures that cause significant clinical morbidity, mortality, and healthcare burden, and there remains a need for additional treatment alternatives. Similarly, bone loss due to hormone ablation in the setting of
'/>"/>

SOURCE Amgen Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
8. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
9. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
10. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... CHAPEL HILL, N.C. , Sept. 4, 2015 ... Science Liaisons (MSLs) and other Field-Based Medical Specialists ... physicians, key opinion leaders, and thought leaders in ... the effectiveness of their field-based teams, companies are ... in order to align countries with corporate objectives ...
(Date:9/4/2015)... 4, 2015  Essilor is pleased to announce the ... against the eyestrain that comes with the constant connection ... as an everyday pair of glasses to provide comfort ... on smart phones, tablets and computers for hours at ... require a prescription but also those who currently wear ...
(Date:9/4/2015)... 2015  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... Wells Fargo Securities 2015 Healthcare Conference in Boston ... th at 2:30 p.m. Eastern Time. To listen to ... visit the Investors section of the Company,s Web site at ... days after the event.  Orexigen Contact: , ...
Breaking Medicine Technology:New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2Essilor Launches New Eyezen Glasses Specifically Designed For A Digital Focused Audience 2
... July 21, 2011 BioMedix™, a leader in providing ... been awarded a U.S. Patent recognizing its innovative solutions ... On July 19, 2011, the United States ... entitled "System and Method for Testing for Cardiovascular Disease," ...
... IRVINE, Calif., July 21, 2011 Endologix, Inc. (NASDAQ: ... aortic disorders, today announced financial results for the three and ... Endologix President and Chief Executive Officer, said, "We are pleased ... to achieve our growth and new product development goals for ...
Cached Medicine Technology:BioMedix™ Receives Patent for Its Innovative Collaborative Care Business Method 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 3Endologix Reports 22% Second Quarter 2011 Revenue Growth 4Endologix Reports 22% Second Quarter 2011 Revenue Growth 5Endologix Reports 22% Second Quarter 2011 Revenue Growth 6Endologix Reports 22% Second Quarter 2011 Revenue Growth 7Endologix Reports 22% Second Quarter 2011 Revenue Growth 8Endologix Reports 22% Second Quarter 2011 Revenue Growth 9
(Date:9/4/2015)... , ... September 04, 2015 , ... Mile High Connects ... in which a lack of funding for sidewalks, bike paths, and other vital supports ... while the Denver region spends billions of dollars to expand public transit, there’s very ...
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one of ... Hampshire fertility "ManchVegas Happy Hour" in Manchester for women who wish to learn more ... XO on Elm restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM to ...
(Date:9/4/2015)... ... 04, 2015 , ... Inmar announced today that its regulatory ... Product, Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. , With the ... goods industry, it can be difficult for companies to navigate, stay abreast of ...
(Date:9/4/2015)... PA (PRWEB) , ... September 04, 2015 , ... Keeping ... in and around the home is quite common. Mold can grow anywhere - on ... around leaking pipes. Checking for excessive moisture and water in the home is key ...
(Date:9/4/2015)... ... September 04, 2015 , ... Mike Day, a former Navy SEAL who was ... Ironman World Championships in Kona on October 10th. , Mike is running the race ... through combat and the cutting-edge treatments that restore their quality of life. ...
Breaking Medicine News(10 mins):Health News:Missed Connections in Metro Denver Transit 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2
... (February 02, 2011) The International Serious Adverse ... with the HMO Research Network (HMORN) to enroll ... may help predict risk associated with a range ... will diversify the iSAEC methods for developing SAE ...
... Ont., Feb. 2, 2011Immigrant women in Ontario are not screened ... lowest rates being among older, poorer South Asians, new research ... of South Asian immigrants over the age of 50 ... according to a study led by doctors at St. Michael,s ...
... thought to be active in killing cells also promotes cellular ... of RIP1 is actually necessary for survival of septic injury, ... potential for developing new treatments for sepsis PROVIDENCE, ... protein that plays a dual role in the liver during ...
... Ritalin may help improve brain function in adolescent rats ... team of Penn State neuroscientists. This may have implications ... found that low doses of Ritalin can help improve ... hurt rather than help the control animals, focus, making ...
... by researchers at the University of Louisville for patients ... functional ability before knee replacement surgery, according to recent ... Research . The study, led by UofL,s ... says gains from exercise before knee replacement or prehabilitation ...
... the health care services can, on the one hand, improve ... other hand, find appropriate ways to care for those suffering ... The cancer care services in Lund, Sweden, set up a ... as 1987. Twenty years later, in 2007, Lund organised the ...
Cached Medicine News:Health News:iSAEC and HMORN to use electronic medical records to research genetics of drug-induced SAEs 2Health News:Screening for cervical cancer low for immigrant women 2Health News:The 'death switch' in sepsis also promotes survival 2Health News:Ritalin may ease early iron deficiency damage 2Health News:Prehabilitation better prepares patients for knee replacement surgery 2Health News:Prehabilitation better prepares patients for knee replacement surgery 3Health News:PanCareSurFup: Major EU project to tackle complications of childhood cancer treatment 2
Sterile squares of textured nylon foil for repair of the floor of the orbit....
The rectangular large-field lens of the 2631 are ideal for reading and writing....
Contour design eyelid implants....
Bausch & Lomb round and rectangular magnifiers incorporate precision optics and an ergonomic design for increased clarity and comfort during use...
Medicine Products: